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ABSTRACT
Objectives To estimate population sodium and potassium 
intakes and explore knowledge, attitudes and behaviour 
(KAB) towards the use of salt in adults in the Sultanate of 
Oman.
Design National cross- sectional population- based survey.
Setting Proportional random samples, representative of 
Omani adults (18 years or older), were obtained from all 
governorates of the Sultanate of Oman.
Participants Five hundred and sixty- nine (193 men, 
376 women; 18 years or older) were included in the 
analysis (response rate 57%). Mean age was 39.4 
years (SD 13.1). Participants attended a screening 
including demographic, anthropometric and physical 
measurements.
Primary and secondary outcome measures We 
assessed dietary sodium, potassium and creatinine by 24- 
hour urinary sodium (UNa), potassium (UK) and creatinine 
(UCr) excretions. We collected KAB by a questionnaire on 
an electronic tablet.
Results Mean UNa was 144.3 (78.8) mmol/day, 
equivalent to 9.0 g of salt/day and potassium excretion 
52.6 (32.6) mmol/day, equivalent to 2.36 g/day, after 
adjusting for non- urinary losses. Men ate significantly 
more sodium and potassium than women. Only 
22% of the sample had a salt intake below the WHO 
recommended target of 5 g/day and less than 10% met 
WHO targets for potassium excretion (>90 mmol/day). 
While 89.1% of those interviewed knew that consuming 
too much salt could cause serious health problems and 
only 6.9% felt they were using too much added salt, 
one in two participants used always or often salt, salty 
seasonings or salty sauces in cooking or when preparing 
food at home.
Conclusions In the Sultanate of Oman, salt consumption 
is higher and potassium consumption lower than 
recommended by WHO, both in men and in women. The 
present data provide, for the first time, evidence to support 
a national programme of population salt reduction to 
prevent the increasing burden of cardiovascular disease in 
the area.
INTRODUCTION
Non- communicable diseases (NCDs) are 
the leading, yet preventable, causes of death 
worldwide.1 The reduction of its burden 
is now a global health priority of the UN,2 
endorsed by the WHO Action Plan that has 
identified a set of cost- effective policy options 
(‘best buys’), of which reduction in popula-
tion salt consumption is one.3
In the Sultanate of Oman, NCDs are among 
the leading causes of death, accounting for 
72% of all deaths.4 Cardiovascular disease 
(CVD) represents an increasingly common 
cause of population morbidity and mortality, 
accounting for 36% of all deaths.4 It represents 
a major public health challenge undermining 
socioeconomic development.5
High blood pressure (BP) and unhealthy 
diets are the leading risk factors for CVD in 
the world.1 Raised BP is a determinant of the 
CVD risk in the Sultanate of Oman, where 
the prevalence of raised BP in people aged 18 
years or older is 33%, higher in men (39%) 
than in women (27%).5 6
High salt (ie, sodium chloride, 
1 g=17.1 mmol of sodium) consumption is an 
important determinant of high BP. A high salt 
Strengths and limitations of this study
 ► National survey of Omani men and women using 24- 
hour urine collections.
 ► Adoption of quality control process to minimise the 
use of incomplete urine collections.
 ► Overall response rate was 57%, comparable with 
other similar population surveys.
 ► Non- responders did not differ in their baseline char-
acteristics from responders.
 ► We cannot rule out the risk of selection bias.
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intake is associated with raised BP that leads to increased 
risk of vascular diseases.7–10 In addition, high salt intake is 
related to adverse health effects independent of its effects 
on BP.11–13 A moderate reduction in salt consumption 
reduces BP7 8 and it can improve the health outcomes and 
indirectly reduce the overall mortality through beneficial 
effect on the BP.9 10
The WHO recommends that adults should consume no 
more than 5 g of salt daily.14 However, mean daily intakes 
of salt in most of the countries in the world exceed this 
recommendation.15 16 While there is no definitive estimate 
of population dietary salt intake in the Sultanate of Oman, 
average consumption could be high, similar to some 
countries in the subregion.17 18 In the Sultanate of Oman, 
it is a common habit to add salt and salty condiments to 
food at the table and while cooking. Also, the habit of 
eating out is increasing (especially in urban areas), which 
leads to an increased salt intake, since restaurants tend 
to use higher amounts of salt to render food tastier. Our 
study was designed to support the salt reduction strategy 
of the Eastern Mediterranean region (EMRO), including 
the Sultanate of Oman, in which monitoring population 
salt consumption is one of the three pillars.19 Current 
national initiatives include establishment of a multi-
sectoral national committee, legislation on salt reduc-
tion, development of salt content benchmarks, dietary 
guidelines.18 The ‘Health Vision 2050’ for the Sultanate 
of Oman was also developed as a roadmap by analysing 
extensively the status of the Omani health system, the 
morbidity and mortality in the population, the challenges 
facing the health system, the expected future develop-
ments and changes in the population including macro-
social and macroeconomic changes in order to augment 
the performance of the health system.
In contrast to sodium, epidemiological and interven-
tion studies suggest beneficial effects of dietary potassium 
on BP and cardiovascular health.20–22 The Sultanate of 
Oman lacks data on actual potassium consumption. The 
WHO currently recommends that adults should consume 
not less than 90 mmol of potassium daily.23 Hence, we 
need reliable data on sodium and potassium intake in the 
Sultanate of Oman.
The primary aim of the present study was to establish 
current baseline average consumption of sodium and 
potassium by 24- hour urine collection, in a national 
random sample of Omani men and women. The study 
also aimed to explore knowledge, attitudes and behaviour 
(KAB) towards dietary salt.
MATERIAL AND METHODS
Participants and recruitment
We nested the salt survey within the main Oman NCD 
survey of 6833 households (online supplemental material 
1, text S1). We recruited only one member per household. 
We designed the salt survey to collect 24- hour urinary 
samples from a subgroup of at least 90 participants from 
each governorate (region). The survey included only 
Omani citizens. We included a total of 999 randomly 
selected Omani men and women. They were all aged 18 
years or older. They comprised residents of all governor-
ates of the Sultanate of Oman (table 1). The sample was 
representative of the national sample for its general char-
acteristics (see online supplemental table 1).
From the sampling frame and according to the 
EMRO- WHO Protocol,24 we excluded the following 
groups: people unable to provide informed consent, 
those with known history of heart or kidney failure, 
stroke, liver disease, those who recently began therapy 
with diuretics (less than 2 weeks), pregnant women, any 
other conditions that would make 24- hour urine collec-
tion difficult. To detect approximately 1 g reduction in salt 
intake over time using 24- hour urinary sodium excretion 
(difference ~20 mmol/24 hours), with an SD of 75 mmol/
day (alpha=0.05, power=0.80), a minimum sample of 120 
individuals per stratum is recommended.24 Thus, we esti-
mated a minimum recommended sample size of 240 per 
age and sex groups and adjusted for an anticipated non- 
response rate of 50%.24 We stratified the population in 
groups by sex (men and women). Therefore, 480 individ-
uals were originally needed to be selected (total n=120×2 
groups/0.5 attrition=480).
The survey took place between December 2017 and 
May 2018. From the 999 individuals interviewed in the 
sampling frame, 569 of them (57.0%) provided suitable 
data for inclusion in the survey analysis. The general 
characteristics of the included participants did not differ 
substantially from those of the excluded participants (see 
online supplemental table 2). Originally, 262 (26.0%) did 
not provide complete urine collections (either declaring 
missing more than one void or providing collections 
<23 hour or above 25 hours), 87 (8.7%) had missing data, 
48 (4.8%) provided urine collections with volume less 
than 500 mL (conventionally taken as not plausible) and 
24 (2.4%) had urinary creatinine excretion outside two 
Table 1 Geographical sampling from the Sultanate of 
Oman
Governorate Valid 24- hour urine collections %
Muscat 67 11.8
Dhofar 79 13.9
Al- Dakhlia 45 7.9
North Sharqiah 36 6.3
South Sharqiah 45 7.9
North Batina 81 14.2
South Batina 53 9.3
Al- Dhahirah 46 8.1
Al Buraymi 84 14.8
Musandam 9 1.6
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SDs of the sex- specific distribution of urinary creatinine 
in the sample (figure 1).
Ethical considerations
We carried out the survey in accordance with the Declara-
tion of Helsinki and Good Clinical Practice.25
Patient and public involvement
No patient involved.
Data collection
We performed the examination in a quiet and comfortable 
room, with the participants who did not smoke, exercise, 
eat and consume caffeine before attending and had been 
instructed to present with a full bladder 30 min before 
measurements to reduce the risk of underestimating the 
urine collection. We carried out the survey in three steps: 
(a) questionnaire survey, (b) physical measurements and 
(c) 24- hour urine collections.
We based the questionnaire on the Core and Expanded 
version of the WHO STEPS Instrument for Chronic 
Disease Risk Factor Surveillance (V.3.0)26 and country- 
specific requirements. It contained 11 core, 1 optional 
and 4 country- specific modules that included a total of 420 
questions, to determine sociodemographic characteristics 
of participants, key behavioural risk factors (tobacco use, 
harmful alcohol consumption, diet with frequency of fruit 
and vegetable consumption, high dietary salt consump-
tion, oil and fat use, physical inactivity), knowledge atti-
tudes and behaviour on dietary salt, given lifestyle advises 
and additional health- related information not presented 
here. KABs towards the consumption of salt were assessed 
by asking participants about the frequency, quantity and 
type of salt used in the household as well as their cooking 
habits and their attitudes and perceptions towards dietary 
salt intake. Processed food was defined, per WHO STEPS 
protocol, as foods altered from their natural state, such 
as packaged salty snacks, canned salty food, cheese and 
processed meat along with country- specific pictorial show 
cards.
We measured anthropometric indices, BP and heart 
rate in all participants. Height was in centimetre and 
body weight in kilogram using a standardised and cali-
brated SECA813 digital floor scales and 213 portable 
stadiometers, respectively. Body mass index (BMI) was 
calculated as weight (kg) divided by height squared 
(m2). Waist and hip circumferences were measured by 
a non- stretch SECA201 measuring tape to the nearest 
millimetre.24 We took systolic and diastolic BP and heart 
rate measurements three times in the right arm on a 
sitting position, using an appropriate cuff and a vali-
dated digital device (OMRON M3). We ignored the first 
measurement and used the mean of second and third 
measurements for analysis. We took measurements after 
the participant had rested for 15 min and each with 
3 min of rest between the measurements (maximum 
deviation of cuff pressure measurement ±3 mm Hg and 
of pulse rate display ±5%). Hypertension is defined as 
systolic and/or diastolic BP >140/90 mm Hg or regular 
antihypertensive treatment.27 We obtained a single 
24- hour urine collection from the participants. We gave 
each participant a leaflet with explanations along with 
the necessary equipment and a record sheet on which 
they noted the start and the finish times of their urine 
collection, any missed urine aliquots and any medication 
taken during the collection. We instructed the partici-
pants carefully on urine collection methodology.24 In an 
effort to minimise bias, we also requested participants 
not to change their diet before or during the day of the 
urine collection. They discarded the first void on waking 
on the day of collection. Participants then filled the 
24- hour urine container over the 24- hour period. On the 
following day, the field team members visited the house-
hold, measured total volume, mixed it thoroughly and 
obtained a urine sample, which was kept in a cool box 
for transport to the respective laboratory. On arrival at 
the laboratory, we either carried out sodium, potassium 
and creatinine determinations immediately or stored 
samples in the fridge until the determination (as soon 
as possible). Sodium and potassium concentration in the 
urine samples were determined using an ion- selective 
electrode with an Abott C8000 & Roche Cobas 6000 and 
expressed in mmol/L.28 Creatinine concentration was 
determined through either the kinetic (Abbott C8000) 
or enzymatic (Roche Cobas 6000) method and expressed 
in mg/dL.29 These determinations were carried out in 
one reference laboratory in each of the 11 governorates, 
except for two regions (Dhofar and Musandam) which 
Figure 1 Stepwise procedure for the selection of valid 
participants according to protocol adherence, quality control 
and completeness of 24- hour urine collections.
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had two receiving reference laboratories each. All labo-
ratories underwent joint quality control.
Statistical analysis
We performed all statistical analyses using the SPSS soft-
ware, V.20 (SPSS). We used t- test for unpaired samples to 
assess differences between group means and Pearson χ2 
test to test the association between categorical variables. 
To convert urinary output into dietary intake, we first 
converted the urinary excretion of sodium (UNa) or potas-
sium (UK) values (mmoL/day) into mg/day (for sodium 
1 mmol=23 mg of sodium, for potassium 1 mmol=39 mg). 
We then multiplied the sodium value by 2.542 to convert 
dietary sodium (Na) intake into salt (NaCl) intake. We 
finally multiplied sodium values by 1.05 (assuming that 
approximately 95% of sodium ingested is excreted).30 We 
calculated potassium dietary intake assuming that 85% 
of the potassium ingested is excreted in the urine.31 The 
results were reported as mean (SD), median (IQ range) 
or as percentages, as appropriate. We considered two- 
sided p below 0.05 as statistically significant.
RESULTS
The final population sample included 569 participants 
between 18 and 69 years old (n=193 or 34% men and 
n=376 or 66% women), recruited nationally.
Characteristics of the participants
Table 2 shows the characteristics of the participants. 
There was no statistically significant difference in the 
mean age and in BMI between men and women, however, 
men had significantly higher BP and slower heart rate 
than women had. The prevalence of hypertension was 
on average of 27.4%, significantly higher in men than in 
women (38.5% vs 21.7%, p<0.001).
Daily urinary excretions of volume, sodium, potassium and 
creatinine and salt and potassium intake
Average urinary volume excretion was 1354 mL/day, being 
higher in men than women (table 3). Average urinary 
creatinine excretion was 1.33 g/day, being again higher 
in men than women (table 3). Mean urinary sodium was 
144.3 (SD 78.8) mmol/24 hours, equivalent to a mean 
consumption of 9.0 (4.9) g of salt per day (table 3). Men 
excreted more sodium than women did (mean differ-
ence 15.0 mmol/24 hours, p<0.05), equivalent to ~1.0 g of 
higher salt consumption than women did. Only 22% of 
the participants met the levels of salt intake of 5 g or less 
recommended by the WHO, with no difference between 
sexes. Mean urinary potassium was 52.6 (32.6) mmol/24 
hours, equivalent to a mean consumption of 2.36 (1.46) g 
of potassium per day (table 3).
Men excreted significantly more potassium than 
women; 9.1% of participants met the levels of potassium 
intake of 90 mmol/day or more recommended by the 
WHO.
The sex difference in total daily salt and potassium 
intakes is almost entirely due to the fact that men eat 
more food than women, as they are taller and heavier, 
despite having comparable BMI. This is a consistent 
finding across populations in different countries and 
from different continents.
KABs towards salt intake and other eating patterns.
KABs towards the consumption of salt are presented in 
table 4. A total of 28.1% of respondents mentioned that 
Table 2 Characteristics of the participants
Variable All (n=569) Men (n=193) Women (n=376)
Age (years) 39.4 (13.1) 38.7 (14.3) 39.8 (12.5)
Height (cm)† 159.4 (11.2) 167.9 (9.7) 154.9 (9.2)‡
Weight (kg)† 74.9 (21.5) 81.4 (22.5) 71.4 (20.1)‡
Body mass index (kg/m2)† 29.3 (7.2) 28.9 (7.6) 29.5 (7.0)
Waist circumference (cm)† 93.8 (15.7) 95.0 (15.7) 93.2 (15.7)
Hip circumference (cm)† 104.5 (15.0) 102.6 (13.7) 105.5 (15.6)§
Systolic blood pressure (mm Hg)* 125.9 (18.2) 134.0 (17.0) 121.7 (17.3)‡
Diastolic blood pressure (mm Hg)* 80.9 (10.7) 83.4 (11.5) 79.7 (10.1)‡
Pulse rate (b/min)* 79.8 (10.5) 78.5 (11.8) 80.4 (9.8)§
Hypertension N (%)* 175 (30.8) 77 (39.9) 98 (26.1)‡
On antihypertensives N (%)* 50 (28.6) 15 (19.5) 35 (35.7)§
Results are mean (SD) or N(%).
Hypertension: Systolic Blood Pressure / Diastolic Blood Pressure >140/90 mm Hg or on current therapy for high blood pressure.
*3 missing values (1m, 2w) (0.5%).
†18 missing values (1m, 17w) (4%).
‡p<0.01.
§p<0.05 when compared with men.
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Table 3 Daily urinary excretions of volume, sodium, potassium and creatinine, estimates of salt and potassium intake and 
proportion of participants meeting WHO recommended targets for salt and potassium consumption.
Variable All (n=569) Men (n=193) Women (n=376)
Volume (mL/24 hours) 1354 (725) 1392 (712) 1335 (731)*
1129 (855–1618) 1150 (900–1721) 1122 (827–1593)
Sodium (mmol/24 hours) 144.3 (78.8) 154.2 (87.4) 139.2 (73.6)*
129.6 (85.7–187.4) 135.4 (87.1–204.8) 126.8 (83.9–179.4)
Potassium (mmol/24 hours) 52.6 (32.6) 56.4 (32.4) 50.6 (32.5)*
46.4 (31.4–64.9) 50.9 (33.8–73.2) 44.7 (30.2–61.6)
Sodium- to- potassium ratio 3.3 (3.4) 3.5 (4.2) 3.2 (2.8)
2.8 (2.0–3.8) 2.7 (1.9–3.9) 2.8 (2.1–3.8)
Creatinine (g/24 hours) 1.33 (0.71) 1.72 (0.87) 1.13 (0.52)‡
1.18 (0.86–1.63) 1.61 (1.16–2.12) 1.02 (0.81–1.36)
Salt intake (g/day) 9.0 (4.9) 9.6 (5.5) 8.7 (4.6)*
8.1 (5.3–11.7) 8.5 (5.4–12.8) 7.9 (5.2–11.2)
Potassium intake (g/day) 2.36 (1.46) 2.53 (1.45) 2.27 (1.46)*
2.08 (1.41–2.91) 2.28 (1.52–3.28) 2.00 (1.35–2.76)
Salt <5 g/day N (%) 124 (21.8) 40 (20.7) 84 (22.3)
Potassium >90 mmol/day N (%) 52 (9.1) 24 (12.4) 28 (7.4)†




Table 4 Knowledge, attitudes and behaviours towards salt consumption
Question All (n=569) Men (n=193) Women (n=376)
How often do you add salt or salty sauces to your food?
  Often/always 28.1% 22.8% 30.8%*
  Sometimes 21.3% 17.1% 23.4%
  Rarely/never 50.6% 60.1% 45.8%
How often is salt, salty seasoning or salty sauces added in cooking or preparing food at home?‡
  Often/always 47.0% 44.8% 48.1%†
  Sometimes 16.5% 12.5% 18.6%
  Rarely/never 36.5 % 42.7% 33.3%
How often do you eat processed food?‡
  Often/always 22.3% 22.8% 22.1%
  Sometimes 38.3% 35.8% 39.5%
  Rarely/never 39.4% 41.4% 38.4%
How much salt or salty sauces do you think you consume?‡
  Too much/far too much 6.9% 7.8% 6.4%
  Just the right amount 66.8% 61.3% 69.7%
  Too little/far too little 26.3% 30.9% 23.9%
Do you think that too much salt or salty sauces could cause a serious health problem?‡
  Yes 89.1% 90.1% 88.6%
*Results are percentages p=0.005.
†p=0.04 when compared with men.
‡Reduced numbers due to missing values.
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they added salt or salty sauces always or often to food. 
The percentage of women who added salt or salty sauces 
always or often to their meal was significantly higher 
than that of men (30.8% vs 22.8%; p=0.005). A total of 
47.0% of respondents reported that they always or often 
added salt, salty seasonings or sauces when cooking or 
preparing food at home, women more than men (48.1% 
vs 44.8%; p=0.04). More than 1 in 5 (22.3%) mentioned 
that they consumed processed foods high in salt always 
or often. Very few (6.9%), however, felt they consumed 
too much salt or salty sauces, although 89.1% knew that 
consuming too much salt could cause serious health 
problems. We also asked participants about dietary atti-
tudes about the consumption of fruit and vegetables, oil 
or fats (table 5). Interestingly, 68.0% consumed fruit at 
least 5 days a week and 54.5% at least three servings on 
these days. Men appeared to report more fruit consump-
tion than women did (40.4% vs 27.7%; p=0.002). Vegeta-
bles were also consumed frequently (75.9% at least 5 days 
a week), with 40.1% having at least three servings on one 
of those days (women more frequently than men). The 
majority (90.8%) used vegetable oil for meal preparation 
in the household and more than half (54.2%) consumed 
food prepared outside home at least once a week. Men 
were more likely than women to do so (67.9% vs 47.2%; 
p<0.001).
DISCUSSION
This is the first nationally representative population- based 
survey carried out in the Sultanate of Oman assessing 
dietary sodium and potassium consumption in adult 
Omani men and women, using the gold standard measure 
of 24- hour urinary sodium and potassium excretions as a 
biomarker of intake. The results show that salt consump-
tion is higher and potassium consumption is lower 
than recommended by the WHO,14 23 both in men and 
women. Average population salt consumption was 9.0 g/
day, almost double the WHO recommended maximum 
population target of 5 g/day.14 Less than one in four 
participants met these targets. Salt consumption varied 
across governorates, being the lowest in South Sharqiah 
(5.3 g/day) and the highest in Al- Dhahirah (14.8 g/day). 
Average population excretion of potassium was 53 mmol/
day (equivalent to about 2.36 g/day), lower than the 
WHO recommended maximum population target of 
>90 mmol/day, equivalent to approximately 3.90 g/day 
(assuming urinary potassium being 85% of the intake).23 
Potassium consumption also varied across governorates, 
being the lowest in Al- Wasta (1.41 g/day) and the highest 
in North Sharqiah (4.25 g/day). The urinary sodium- to- 
potassium ratio averaged 3.3, with no difference between 
men and women. Findings from the International Collab-
orative Study on Salt (INTERSALT) study showed that a 
difference in sodium- to- potassium ratio from 3.1 to 1.0 
was associated with a 3.36 mm Hg difference in popula-
tion systolic BP.32 33 The Trial Of Hypertension Prevention 
(TOHP) study reported a direct association between the 
urinary sodium- to- potassium ratio and CVD.10 34 35 More-
over, a unit difference in the ratio would be associated 
with a 13% reduction in total mortality.35 Measuring the 
ratio is obviously important, although no evidence- based 
global guidelines have determined population targets, as 
yet.
Our questionnaire revealed that half of the popula-
tion seen often used sauces and condiments (invariably 
containing high concentrations of salt) but only 10% 
believed this was too much. A quarter of the surveyed 
population added salt to food regularly, one in five ate 
processed food often and more than half of the popu-
lation ate out at least once a week, with men more likely 
than women. These results, in addition to those obtained 
in previous surveys on unhealthy dietary habits, support 
the National Health Vision set by the Sultanate of Oman 
to reduce the burden of CVD.36 This document sets the 
health visions for the country in 40 years. The compre-
hensive analyses of many factors affecting the population 
health and the healthcare system indicate that NCDs, 








In a typical week, on how many days do you eat fruit?§
  <5 32.0% 40.4% 27.7%†
  >5 68.0% 59.6% 72.3%
How many servings of fruit do you eat on one of those 
days?§
  <3 45.5% 41.8% 47.2%
  >3 54.5% 58.2% 52.8%
In a typical week, on how many days do you eat 
vegetables?§
  <5 24.1% 24.9% 23.7%
  >5 75.9% 75.1% 76.3%
How many servings of vegetables do you eat on one of 
those days?§
  <3 59.9% 65.9% 56.9%‡
  >3 40.1% 34.1% 43.1%
What type of oil or fat is most often used for meal 
preparation in your household?§
  Vegetable oil 90.8% 91.1% 90.7%
  Other (lard, suet, butter, 
ghee)
9.0% 8.9% 9.0%
None used 0.2% 0 0.3%
On average, how many meals per week do you eat that were 
not prepared at home?§
  0 45.8% 32.1% 52.8%*
  >1 54.2% 67.9% 47.2%
*Results are percentages p<0.0001.
†p=0.002.
‡p=0.04 versus men.
§Reduced numbers due to missing values.
 on N
ovem









pen: first published as 10.1136/bm





7Al- Mawali A, et al. BMJ Open 2020;10:e037012. doi:10.1136/bmjopen-2020-037012
Open access
in the context of increased life expectancy and popu-
lation ageing, pose a significant threat to the health of 
the Omani people and it identifies the need to be able 
to respond to this challenge. Population salt reduction is 
one of the priorities.
Comparison with countries of the Gulf Co-operation Council 
and of the Arab Peninsula
In the Gulf Co- operation Council (GCC) countries, 
populations lead a sedentary lifestyle, both hypertension 
and obesity are common17 and they are major contrib-
utors to NCDs.37 The estimated total mortality in GCC 
countries attributable to NCDs varies from 65% to 78%, 
with the highest estimates in Bahrain and Saudi Arabia 
and the lowest in Oman and Qatar, respectively.37 Salt 
intake is deemed high in most countries of the EMRO 
Region, although there are only a few studies that directly 
measured population levels, with inconsistent results due 
to methodological inadequacies.17 18 The Global Burden 
of Disease (GBD) estimates of average salt consumption 
using a Bayesian model suggest that salt consumption in 
GCC countries may vary from 8.0 g/day in Saudi Arabia to 
13.5 g/day in Bahrain.38 Estimates of salt intake in neigh-
bouring countries would also range between 7.8 g/day in 
Lebanon and 10.3 g/day in Jordan.38 The present study is 
one of the few nationally representative surveys in GCC 
countries using the gold standard method of assessment 
of dietary salt intake. Its results suggest an intake close 
to that estimated by the GBD. In addition to the GBD, 
however, our study also provides, for the first time, direct 
measures of average population potassium consumption 
also targeted by WHO recommendations for cardiovas-
cular prevention.20 23
Many countries of the EMRO Region of WHO are 
developing and/or implementing national initiatives 
to decrease population salt intake.18 National initiatives 
include the establishment of national multisectoral 
committees, the engagement of the government through 
regulatory measures and legislation (Bahrain, Iran, 
Jordan, Oman, Qatar), the specification of the food cate-
gories prioritised for action such as bread (Kuwait, Qatar) 
and canned foods (Iran), the development of national 
benchmarks and targets (Bahrain, Iran, Oman), dietary 
guidelines (Afghanistan, Lebanon, Oman, Saudi Arabia), 
media awareness campaigns (Lebanon, United Arab 
Emirates), salt labelling, collaborative actions involving 
the food industry and/or restaurants and food caterers 
(Kuwait, Qatar, United Arab Emirates) and the moni-
toring and evaluation of sodium intakes and salt content 
of foods (Iran, Lebanon, Oman, Qatar).
Comparisons with studies in other countries
National salt and potassium consumption surveys have 
been carried out in almost all regions of the world, espe-
cially in response to the recommendations from the 
WHO that identified population salt reduction as one of 
the most cost- effective and feasible approaches to prevent 
NCDs.2 3 Globally, there is a high variation in the readiness 
of countries to adopt and implement the different aspects 
of the overall strategy, with low- income and middle- 
income countries still lagging behind.39 40 Nevertheless, 
where surveys have been carried out to establish the size 
of the problem, average levels of salt intake have been 
very high in countries of Eastern Europe (10.8 g/day in 
Moldova and 11.6 g/day in Montenegro with potassium 
about 30% lower than recommended and sodium- to- 
potassium ratios of 3.0 and 2.4, respectively),41 42 Central 
Asia (17.2 and 18.8 g/day in two sites of Kazakhstan),43 
China (twofold North- South gradient from 15.6 to 
8.4 g/day and potassium about 60% lower than recom-
mended)44 and Australasia (about 9.0 g/day weighted 
means in Australia and 11.7 g/day in the Fiji Islands),45 46 
indicating urgent need for population interventions. The 
same studies have invariably indicated lower than recom-
mended potassium excretion and high sodium- to- 
potassium ratio. In this respect, the average intake of 
sodium in Oman seems reassuring, as the achievement 
of the set targets appears more feasible that in other 
countries where intake currently still exceeds 10 g/day. 
However, potassium consumption is nearly half of what is 
recommended,23 resulting in a high sodium- to- potassium 
ratio.
Strengths and limitations
Our study has several strengths. First, it is a population- 
based survey across the whole country. Second, it included 
all adults. Third, it included both men and women. These 
study characteristics would allow with greater confidence 
the extrapolation of results to the whole country popu-
lation, rather than those conducted in selected groups 
including patients,47 young female university students48 or 
children.49 Fourth, it used the current preferred method-
ology for estimating salt consumption. Fifth, we applied 
a rigorous quality control protocol to ensure complete-
ness of urine collections and to minimise both under and 
overestimations. Current recommendations suggest the 
use of single complete 24‐hour urine samples, collected 
from a representative population sample to assess the 
population’s current 24‐hour dietary sodium ingestion.50 
The role of single- spot or short duration timed urine 
collections in assessing population average sodium intake 
requires more research. Single or multiple spot or short 
duration timed urine collections are, on the other hand, 
not recommended for assessing an individual’s sodium 
intake especially in relationship to health outcomes.50 
Twenty- four- hour diet recall and diet records inaccurately 
measure dietary sodium intake in individuals compared 
with the gold standard 24- hour urinary excretion.51 
Furthermore, there is poor agreement between estimates 
of sodium intake from food- frequency questionnaires and 
24- hour urine samples.52 Sixth, it has measured directly the 
amount of potassium consumption, additional nutrient 
targeted for cardiovascular prevention.20 23 Seventh, we 
standardised fieldwork and used standardised laboratory 
methodologies across the country. Eighth, all laboratories 
underwent joint quality control.25
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There are limitations too. First, we included only 57% 
of the urine samples originally collected from willing 
individuals. This was due to the stringent quality control 
that has led to the exclusion of incomplete or erroneous 
collections.24 This could have introduced a self- selection 
bias. The comparison of the baseline characteristics of the 
studies sample versus the excluded group suggests that 
the two groups were comparable for general characteris-
tics, with the exception of the latter being 2 years younger 
and having a 1.8 mm Hg lower diastolic BP. Second, we 
assessed urinary sodium and potassium excretions only 
once. While we cannot characterise an individual’s intake 
in such a way,50 there is less likelihood of a bias of group 
estimates. Third, although we requested participants not 
to change their diet prior to urine collection, it would 
be difficult to rule out entirely any bias during collec-
tion. Fourth, although we administered a questionnaire 
to derive KABs towards the use of salt, we were unable 
to establish the relative contribution of discretionary 
sources of salt and the most common foods contributing 
to salt as well as potassium consumption.
Potential impact
The population in the Sultanate of Oman is of just over 
5 million (Ministry of Health Annual Health Report, 
2018 estimates), of which about 2.3 million are Omani 
nationals4 (surveyed in the present study). Approximately 
51% are 25 years or older. To meet a 30% reduction in 
population salt consumption set by WHO by 2025, the 
Sultanate of Oman should aim at a 2.7 g/day salt reduction 
nationally. This reduction would avert 8.1% CVD deaths 
per year and more non- fatal events and disabilities.2 Addi-
tional benefits would be achieved if we increased at the 
same time population potassium intake towards WHO set 
targets, leading to a significant reduction in the sodium- 
to- potassium ratio in the diet. This could be achieved not 
only by increasing consumption of plant- based foods but 
also by enriching the diet with potassium- rich salt substi-
tution in food manufacturing and processing or by using 
potassium- reach salts instead of sodium chloride, where 
sodium intake is predominantly originating from discre-
tionary sources. Potassium- rich salts lower BP effectively53 
and the potential risk associated with potassium supple-
mentation used at a population level54 would be offset by 
a net reduction in CVD deaths.55
Policy implications
The Sultanate of Oman has embraced among its health 
priorities the prevention and control of NCDs and 
improvement in nutrition4 in line with the strategic 
directions of WHO endorsed by the EMRO in 2012 and 
201318. Since then several countries have conducted 
dietary studies in an attempt to assess the population’s 
salt and potassium intake.18 Studies in the area have also 
attempted to identify the major dietary contributors to 
sodium intake. Studies are still limited and there are large 
variations in dietary habits in the region due to cultural, 
ethnic, religious and social heterogeneity. The most 
common source of salt consumption across the region 
is bread,18 56 in all its different forms, with other sources 
being more relevant in different countries. In Lebanon57 
and Bahrain,58 dairy products are common sources, while 
in Morocco,59 major contributors to salt consumption 
include cereal- based products, spices and condiments 
and milk products. These indications, together with 
the awareness and behaviours measured, suggest that 
to reduce population salt consumption in the Sultanate 
of Oman, the following initiatives should be taken: (a) 
improving salt- related knowledge through health promo-
tion campaigns, (b) measuring major sources of salt 
consumption, (c) establishing collaborations with local 
authorities to reduce the amount of salt used in tradi-
tional bread making and locally produced condiments, 
(d) adopting a labelling strategy for imported foods with 
high salt content. In addition, the Ministry of Health 
should develop strategies and methodologies to measure 
the indicators of population salt consumption.60
CONCLUSIONS
This study demonstrates that salt consumption in the 
Sultanate of Oman is high and should be reduced through 
a public health action aiming at the entire population. 
Likewise, potassium consumption is particularly low. The 
KABs survey indicates areas of limited awareness. Educa-
tion of the dangers of high salt consumption and where 
salt is hidden, of the benefits of increasing potassium 
through fruit, vegetables, nuts and legumes, alongside 
accurate labelling and marketing of food, surveillance to 
measure and monitor salt use and reformulating bread 
are all important elements of an effective national salt 
reduction programme.18 19 61
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